Advertisement
Research ArticleArticle

Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands

Brady K. Atwood, James Wager-Miller, Christopher Haskins, Alex Straiker and Ken Mackie
Molecular Pharmacology February 2012, 81 (2) 250-263; DOI: https://doi.org/10.1124/mol.111.074013
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleArticle

Functionally Selective CB2 Ligands

Brady K. Atwood, James Wager-Miller, Christopher Haskins, Alex Straiker and Ken Mackie
Molecular Pharmacology February 1, 2012, 81 (2) 250-263; DOI: https://doi.org/10.1124/mol.111.074013
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section